KING PHARMS LLC
Big PharmaKING PHARMS LLC is a major pharmaceutical company focused on Infectious Disease, Dermatology, Oncology.
KING PHARMS LLC's Key Drugs
KING PHARMS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
KING PHARMS LLC's Recent FDA Approvals
New NDA/BLA approvals for KING PHARMS LLC over the last two years — novel drugs only, excluding generics and label supplements.
KING PHARMS LLC's Therapeutic Areas
KING PHARMS LLC's approved drugs and pipeline span 4 therapeutic areas, led by Infectious Disease and Dermatology, across 0 biologic and 6 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
KING PHARMS LLC's Top Competitors
KING PHARMS LLC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
KING PHARMS LLC Pipeline Snapshot
Active clinical trials for KING PHARMS LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1948-04-26
- Latest
- 2026-06-25
- Applications
- 28